» Articles » PMID: 34676372

Electrolyte Changes in Contemporary Hemodialysis: A Secondary Analysis of the Monitoring in Dialysis (MiD) Study

Abstract

Background: There is a paucity of contemporary data examining electrolyte changes during and immediately after hemodialysis (HD), and their relationship with dialysate prescriptions. The present study examines these relationships.

Methods: We analyzed patient- (n=66) and HD session-level pre- and post-dialysis laboratory data (n=1,713) over a six-month period from the Monitoring in Dialysis Study. We fit mixed effects regression models to analyze electrolyte, blood urea nitrogen, creatinine, and albumin levels immediately post-HD, accounting for pre-HD and dialysate prescriptions. In a subset of US patients (n=40), 15-minute post-HD and 30-minute post-HD values were available at one session. Predictive models were fit to estimate electrolyte levels immediately post-HD, accounting for pre-HD concentrations and dialysate prescriptions.

Results: Serum bicarbonate, calcium, and albumin increased (mean increase 4.9±0.3 mEq/L, 0.7±0.1 mEq/L, and 0.4±0.03 g/dL, respectively), whereas potassium, magnesium, and phosphorus decreased immediately post-HD (mean -1.2±0.1 mEq/L, -0.3±0.03 mEq/L, and -3.0±0.2 mg/dL, respectively). Hypokalemia and hypophosphatemia were present in 40% of and 67% of immediate post-HD samples, respectively. Dynamic changes were observed in electrolyte concentrations at 15- and 30-minutes post-HD, compared to immediately post-HD.

Conclusion: We describe the magnitude of post-dialytic changes in serum electrolytes with contemporary HD, reporting a high incidence of electrolyte abnormalities post-HD, and present predictive nomograms relating electrolyte changes immediately post-HD to dialysate prescriptions. Our results may be useful for clinical care and provide insights for future research on dialysate prescriptions.

Citing Articles

Research on the development of an intelligent prediction model for blood pressure variability during hemodialysis.

Ren Z, Zhang M, Wang P, Chen K, Wang J, Wu L BMC Nephrol. 2025; 26(1):82.

PMID: 39962403 PMC: 11834630. DOI: 10.1186/s12882-025-03959-x.


Intradialytic cardiovascular injury is lowest in high-volume haemodiafiltration: a randomized cross-over trial in four intermittent dialysis strategies.

Liu P, Rootjes P, de Roij van Zuijdewijn C, Hau C, Nube M, Nieuwland R Clin Kidney J. 2024; 17(6):sfae134.

PMID: 39502770 PMC: 11536140. DOI: 10.1093/ckj/sfae134.


Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study.

Ravi K, Tumlin J, Roy-Chaudhury P, Koplan B, Costea A, Kher V Kidney360. 2024; 5(10):1490-1499.

PMID: 39480910 PMC: 11556930. DOI: 10.34067/KID.0000000000000537.


Use of Neuromuscular Blocking and Antagonism Agents across the Spectrum of Renal Impairment Undergoing Major Inpatient Surgery: A Single-center Retrospective Observational Cohort Study.

Colquhoun D, Kumar S, Jewell E, Mentz G, Bickett-Hickok R, Kheterpal S Anesthesiology. 2024; 141(3):602-607.

PMID: 39136482 PMC: 11328960. DOI: 10.1097/ALN.0000000000005079.


Dialysis-Reversible Complete Heart Block Without Severe Metabolic Derangements.

Ring S, Llop A, Khawaja H, Khan U, Khan M Cureus. 2024; 16(5):e60339.

PMID: 38751404 PMC: 11095058. DOI: 10.7759/cureus.60339.